Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults
Clinical trial NCT05118386 · COMPLETED
Trial details
- NCT number
- NCT05118386
- Sponsor
- Gates Medical Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2022-08-23
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.